S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel P. Petrylak, MD
Herbert Irving Comprehensive Cancer Center
Study Chair - Patrick A. Burch, MD
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ccop - Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Siouxland Hematology-Oncology
Sioux City, Iowa, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Centracare Health Plaza
Saint Cloud, Minnesota, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Medcenter One Health System
Bismarck, North Dakota, United States
- Ccop - Merit Care Hospital
Fargo, North Dakota, United States
- Altru Health System
Grand Forks, North Dakota, United States
- Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
- Rapid City Regional Hospital
Rapid City, South Dakota, United States
- Ccop - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 1999
- Primary completion
- 31 Jul 2006
- Completion
- 31 Jan 2007
- Last update posted
- 25 Feb 2014
- Registered enrollment
- 770
- Registry id
- NCT00004001
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.